ATE212616T1 - 7-amino-2-heptenoate und ihre verwendung in der herstellung von methylphenidat - Google Patents

7-amino-2-heptenoate und ihre verwendung in der herstellung von methylphenidat

Info

Publication number
ATE212616T1
ATE212616T1 AT97908413T AT97908413T ATE212616T1 AT E212616 T1 ATE212616 T1 AT E212616T1 AT 97908413 T AT97908413 T AT 97908413T AT 97908413 T AT97908413 T AT 97908413T AT E212616 T1 ATE212616 T1 AT E212616T1
Authority
AT
Austria
Prior art keywords
pct
methylphenidate
blocking group
cooch3
sec
Prior art date
Application number
AT97908413T
Other languages
English (en)
Inventor
Martin Edward Fox
Jane Marie Paul
Original Assignee
Medeva Europ Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medeva Europ Ltd filed Critical Medeva Europ Ltd
Application granted granted Critical
Publication of ATE212616T1 publication Critical patent/ATE212616T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT97908413T 1996-03-27 1997-03-21 7-amino-2-heptenoate und ihre verwendung in der herstellung von methylphenidat ATE212616T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9606417.5A GB9606417D0 (en) 1996-03-27 1996-03-27 Asymmetric cyclisation
PCT/GB1997/000811 WO1997035836A1 (en) 1996-03-27 1997-03-21 7-amino-2-heptenoates and their use in the preparation of methylphenidate

Publications (1)

Publication Number Publication Date
ATE212616T1 true ATE212616T1 (de) 2002-02-15

Family

ID=10791096

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97908413T ATE212616T1 (de) 1996-03-27 1997-03-21 7-amino-2-heptenoate und ihre verwendung in der herstellung von methylphenidat

Country Status (14)

Country Link
US (1) US6031124A (de)
EP (1) EP0889874B1 (de)
JP (1) JP2000507263A (de)
KR (1) KR100472753B1 (de)
AT (1) ATE212616T1 (de)
AU (1) AU703927B2 (de)
CA (1) CA2243544C (de)
DE (1) DE69710181T2 (de)
DK (1) DK0889874T3 (de)
ES (1) ES2172767T3 (de)
GB (1) GB9606417D0 (de)
MX (1) MX202731B (de)
PT (1) PT889874E (de)
WO (1) WO1997035836A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922736A (en) * 1995-12-04 1999-07-13 Celegene Corporation Chronic, bolus administration of D-threo methylphenidate
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US6486177B2 (en) * 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
EP0860426A1 (de) * 1997-02-19 1998-08-26 Takasago International Corporation 7-(N-Substituierte amino)-2-Phenylheptanoic Säure Derivaten, und Verfahren zur Herstellung
US5859249A (en) * 1997-02-19 1999-01-12 Takasago International Corporation 2-phenyl-2-(2'-piperidinylidene)acetate derivative, process for manufacturing the same, and process for manufacturing optically active 2-phenyl-2-(2'-piperidinyl)acetate derivative by asymmetrically hydrogenating the same
US6962997B1 (en) 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
US6100401A (en) * 1998-04-20 2000-08-08 Novartris Ag Process for preparing the d-threo isomer of methylphenidate hydrochloride
US6025502A (en) * 1999-03-19 2000-02-15 The Trustees Of The University Of Pennsylvania Enantopselective synthesis of methyl phenidate
US20050239830A1 (en) * 2004-04-26 2005-10-27 Vikram Khetani Methods of diminishing co-abuse potential
US20060127421A1 (en) * 2004-12-09 2006-06-15 Celgene Corporation Treatment using D-threo methylphenidate
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US8916588B2 (en) 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US10292937B2 (en) 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US8927010B2 (en) 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
AU2012230733B2 (en) 2011-03-23 2016-10-20 Ironshore Pharmaceuticals & Development, Inc. Methods and compositions for treatment of attention deficit disorder
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2957880A (en) * 1953-12-23 1960-10-25 Ciba Pharm Prod Inc Process for the conversion of stereoisomers
JPS537627A (en) * 1976-07-07 1978-01-24 Teijin Ltd Optically active unsaturated esters and their preparation

Also Published As

Publication number Publication date
EP0889874A1 (de) 1999-01-13
US6031124A (en) 2000-02-29
CA2243544C (en) 2002-11-19
AU703927B2 (en) 1999-04-01
DE69710181T2 (de) 2002-08-14
EP0889874B1 (de) 2002-01-30
DK0889874T3 (da) 2002-05-06
AU2038697A (en) 1997-10-17
MX9807879A (en) 1999-02-28
KR19990087826A (ko) 1999-12-27
ES2172767T3 (es) 2002-10-01
KR100472753B1 (ko) 2005-07-07
CA2243544A1 (en) 1997-10-02
GB9606417D0 (en) 1996-06-05
WO1997035836A1 (en) 1997-10-02
MX202731B (en) 2001-06-29
DE69710181D1 (de) 2002-03-14
JP2000507263A (ja) 2000-06-13
PT889874E (pt) 2002-06-28

Similar Documents

Publication Publication Date Title
ATE212616T1 (de) 7-amino-2-heptenoate und ihre verwendung in der herstellung von methylphenidat
DE59610509D1 (de) Neue 4-(oxyalkoxyphenyl)-3-oxy-piperidine zur behandlung von herz- und niereninsuffizienz
DE60236600D1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
ATE223407T1 (de) Halogenpyrimidine und ihre verwendung als schädlingsbekämpfungsmittel
ATE255604T1 (de) Verfahren zur herstellung von polyalkenaminen
ATE187724T1 (de) Azachinoxaline, verfahren zu ihrer herstellung und ihre verwendung
ATE231505T1 (de) Neue heterocyclische/cyclische amine
DE69527429D1 (de) Verfahren zur herstellung von wasserfreien und hydrat-formen von antihistaminischen piperinderivaten, polymerphe und pseudomorphe davon
DE69225888D1 (de) Katalase, ihre herstellung und verwendung
DE69433984D1 (de) Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d
DE69009746D1 (de) Derivate von n-phenylbenzamid mit antiulcerativer sowie antiallergischer aktivität und verfahren zu ihrer herstellung.
DE69708848D1 (de) Mischung von erdalkalialkylarylsulfonaten, ihre verwendung als schmierölzusatz und herstellungsmethode
ATE178886T1 (de) 1-aryl-2-acylamino-ethan-verbindungen und ihre verwendung als neurokinin- insbesondere als neurokinin-1-antagonisten
ATE181056T1 (de) Arylessigsäurederivate und ihre verwendung als fungizide
ATE237585T1 (de) Substituierte 3,3-diamino-2-propennitrile, ihre herstellung und verwendung
BG104232A (bg) Заместени 1,2,3,4,5,6-хексахидро-2,6-метано-3-бензазоцин- 10-оли, метод за тяхното получаване и приложението им като лекарствени средства
TR199901416T2 (xx) Heterosiklik karbonikasit t�revleri.
ATE85327T1 (de) Substituierte pyridylethanolamine, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer bei tieren.
DE69504198D1 (de) Substituierte alkyldiaminderivate und ihre verwendung als tachykinin antagonisten
DE69331293D1 (de) Pyridiniumderivate und ihre Verwendung zur Bestimmung von Bindegewebeerkrankungen bei Menschen und Tieren
ATE8046T1 (de) Dibenzofuranderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von pilzen.
ATE259817T1 (de) Herstellung von einem clavulansäuresalz
ATE9337T1 (de) N-substituierte 2-methylnaphthylamide, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von pilzen.
ATE151422T1 (de) 8-azabicyclo(3.2.1>octylalkylthiazolidinone, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
PL322969A1 (en) Substituted phenylamidines, pharmaceutic compositions containing theses compounds and method of obtaining them

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee